Equus asinus (ass): 106830081
Help
Entry
106830081 CDS
T04645
Symbol
CASP3
Name
(RefSeq) caspase-3 isoform X1
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
eai
Equus asinus (ass)
Pathway
eai01524
Platinum drug resistance
eai04010
MAPK signaling pathway
eai04115
p53 signaling pathway
eai04148
Efferocytosis
eai04210
Apoptosis
eai04215
Apoptosis - multiple species
eai04623
Cytosolic DNA-sensing pathway
eai04650
Natural killer cell mediated cytotoxicity
eai04657
IL-17 signaling pathway
eai04668
TNF signaling pathway
eai04726
Serotonergic synapse
eai04932
Non-alcoholic fatty liver disease
eai04933
AGE-RAGE signaling pathway in diabetic complications
eai04936
Alcoholic liver disease
eai05010
Alzheimer disease
eai05012
Parkinson disease
eai05014
Amyotrophic lateral sclerosis
eai05016
Huntington disease
eai05020
Prion disease
eai05022
Pathways of neurodegeneration - multiple diseases
eai05132
Salmonella infection
eai05133
Pertussis
eai05134
Legionellosis
eai05145
Toxoplasmosis
eai05146
Amoebiasis
eai05152
Tuberculosis
eai05160
Hepatitis C
eai05161
Hepatitis B
eai05162
Measles
eai05163
Human cytomegalovirus infection
eai05164
Influenza A
eai05165
Human papillomavirus infection
eai05167
Kaposi sarcoma-associated herpesvirus infection
eai05168
Herpes simplex virus 1 infection
eai05169
Epstein-Barr virus infection
eai05170
Human immunodeficiency virus 1 infection
eai05200
Pathways in cancer
eai05203
Viral carcinogenesis
eai05205
Proteoglycans in cancer
eai05206
MicroRNAs in cancer
eai05210
Colorectal cancer
eai05222
Small cell lung cancer
eai05416
Viral myocarditis
eai05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
eai00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
106830081 (CASP3)
04668 TNF signaling pathway
106830081 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
106830081 (CASP3)
09143 Cell growth and death
04210 Apoptosis
106830081 (CASP3)
04215 Apoptosis - multiple species
106830081 (CASP3)
04115 p53 signaling pathway
106830081 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
106830081 (CASP3)
04650 Natural killer cell mediated cytotoxicity
106830081 (CASP3)
04657 IL-17 signaling pathway
106830081 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
106830081 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
106830081 (CASP3)
05206 MicroRNAs in cancer
106830081 (CASP3)
05205 Proteoglycans in cancer
106830081 (CASP3)
05203 Viral carcinogenesis
106830081 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
106830081 (CASP3)
05222 Small cell lung cancer
106830081 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
106830081 (CASP3)
05161 Hepatitis B
106830081 (CASP3)
05160 Hepatitis C
106830081 (CASP3)
05164 Influenza A
106830081 (CASP3)
05162 Measles
106830081 (CASP3)
05168 Herpes simplex virus 1 infection
106830081 (CASP3)
05163 Human cytomegalovirus infection
106830081 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
106830081 (CASP3)
05169 Epstein-Barr virus infection
106830081 (CASP3)
05165 Human papillomavirus infection
106830081 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
106830081 (CASP3)
05133 Pertussis
106830081 (CASP3)
05134 Legionellosis
106830081 (CASP3)
05152 Tuberculosis
106830081 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
106830081 (CASP3)
05145 Toxoplasmosis
106830081 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
106830081 (CASP3)
05012 Parkinson disease
106830081 (CASP3)
05014 Amyotrophic lateral sclerosis
106830081 (CASP3)
05016 Huntington disease
106830081 (CASP3)
05020 Prion disease
106830081 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
106830081 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
106830081 (CASP3)
05416 Viral myocarditis
106830081 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
106830081 (CASP3)
04932 Non-alcoholic fatty liver disease
106830081 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
106830081 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
106830081 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
eai01002
]
106830081 (CASP3)
Enzymes [BR:
eai01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
106830081 (CASP3)
Peptidases and inhibitors [BR:
eai01002
]
Cysteine peptidases
Family C14: caspase family
106830081 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
Peptidase_C14
Tli4_C
Motif
Other DBs
NCBI-GeneID:
106830081
NCBI-ProteinID:
XP_044616495
LinkDB
All DBs
Position
27:complement(14747104..14767526)
Genome browser
AA seq
277 aa
AA seq
DB search
MENSKISVDSKSIKNSETKILHGSKSMDSGISLDSSYKMDYPEMGLCIIINNKNFHKSTG
MASRSGTDVDAANLRETFTNLKYEVRNKNDLTGEEIVELMRSVSKEDHSKRSSFICVLLS
HGEEGIIFGTNGPIDLKKLTCFFKGDCCRSLAGKPKLFIIQACRGTELDSGIETDSGIED
DMTCQKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKLYAHKLELMHILTRVN
RKVAMEFESYCLDPTFHGKKQIPCIVSMLTKELYFYH
NT seq
834 nt
NT seq
+upstream
nt +downstream
nt
atggagaactctaaaatctcagtggattcaaaatccattaaaaattcagaaacaaagatc
ttacatggaagcaagtcaatggactctggaatatccttggacagtagttacaaaatggat
tatcctgaaatggggttatgtataataatcaataataagaactttcataaaagtactgga
atggcatcccggtctggtacagatgtggatgcagcaaacctcagggaaacattcacaaac
ttgaaatacgaagtcaggaataaaaatgatcttaccggcgaagaaattgtggaattgatg
cgcagtgtttctaaagaagatcatagcaaaaggagcagttttatttgcgtgcttctaagc
catggtgaagaaggaataatttttggaacaaatggacctattgacctgaaaaaattaact
tgtttcttcaaaggggattgttgcagaagtctagctggaaaacccaaacttttcattatt
caggcctgccgaggtacagaactggacagtggtattgagaccgacagtggtattgaggat
gacatgacgtgtcagaaaatcccagttgaggcagacttcctgtatgcgtattccacagca
cctggttactattcctggcgaaattcgaaggacggatcctggttcatccagtcgctttgt
gctatgctgaagctgtacgcccacaagcttgagcttatgcatatcctcactcgggttaac
cgcaaggtagccatggaatttgagtcctattgccttgaccctacttttcatggaaagaaa
cagattccgtgtattgtttctatgctcacaaaagaactgtatttttatcactaa
DBGET
integrated database retrieval system